Alveolar Bone Regeneration with Advanced Platelet-Rrich Fibrin and Strontium-Doped Hydroxyapatite
Official title: Evaluation of Alveolar Bone Regeneration Using Advanced Platelet-Rich Fibrin Combined With Strontium-Doped Hydroxyapatite: A Randomized Clinical Study
Run by Kafrelsheikh University · NCT07918014 · Data updated 2026-11-12
This study tests whether using advanced platelet-rich fibrin (A-PRF) alone or with strontium-doped hydroxyapatite (Sr-HA) helps regenerate bone after tooth extraction better than letting the socket heal on its own.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Kafrelsheikh University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Kafr ash Shaykh, Kafr Elsheikh) |
| Status | Recruiting |
| Started | August 1, 2026 |
| Main results expected | December 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07918014 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-60 requiring tooth extraction with preserved sockets and sufficient surrounding bone walls, in good oral health and able to follow study visits.
✕Probably not a fit
Patients with conditions or factors that severely impair bone healing or those not meeting eligibility may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares three approaches for preserving the tooth extraction socket: A-PRF alone, A-PRF combined with Sr-HA, and spontaneous healing without graft material. The goal is to see which method best supports alveolar bone regeneration. A-PRF provides a fibrin matrix rich in platelets and cells, while Sr-HA is a bone substitute designed to enhance remodeling. Participants are adults needing tooth extractions with intact sockets and adequate surrounding bone walls. Outcomes focus on bone regeneration and healing in the extraction sites over follow-up visits.
Why it matters
Potential benefit: If successful, the combination or use of A-PRF could improve bone regeneration after extraction, potentially preserving alveolar ridge structure.
How similar studies have gone: Previous work supports the use of platelet concentrates and bone substitutes to aid bone healing, but specific combinations with Sr-HA in this context are being explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged between 18 and 60 years. * Both male and female patients. * Indicated for extraction of teeth with preservation of intact extraction sockets. * Presence of adequate surrounding bone walls suitable for socket preservation. * Good oral hygiene and acceptable plaque control. * Systemically healthy patients or those with medically controlled conditions that do not interfere with bone healing. * Ability and willingness to comply with the study protocol and follow-up visits. Exclusion Criteria: * Pregnancy or lactation. * Current smokers or tobacco users. * Uncontrolled diabetes mellitus or systemic diseases affecting bone metabolism or wound healing. * History of radiotherapy or chemotherapy involving the head and neck region. * Active acute infection at the extraction site. * History of bisphosphonate therapy or long-term corticosteroid use. * Bleeding disorders or anticoagulant therapy contraindicating blood collection. * Previous regenerative procedures at the intended surgical site within the preceding six months. * Patients unable or unwilling to attend scheduled follow-up visits.
Where it's running
-
Kafr Elsheikh University
Kafr ash Shaykh, Kafr Elsheikh, Egypt Recruiting
Study contacts
- Study coordinator: Abdulkarim J Al-Jahed, B.Sc
- Email: dr.abdulkareemaljahed@gmail.com
- Phone: 00201121618187
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
i-PRF bioactive matrix with coronally advanced flap vs connective tissue graft for gingival recessions
This trial tests whether a bioactive matrix made with i-PRF and L-PRF, used with a coronally advanced flap, can provide similar or better root coverage than a traditional connective tissue graft in adults with Miller Class I or II gingival recessions.
-
Injectable platelet-rich fibrin with a minimally invasive non-surgical technique for treating intrabony periodontal defects
This study tests whether adding injectable platelet-rich fibrin to a minimally invasive non-surgical treatment helps regenerate bone in intrabony periodontal defects.
-
Treatment of peri-implantitis using platelet-rich fibrin
This study is testing whether adding platelet-rich fibrin to surgery can help people with peri-implantitis heal better and improve bone growth around their dental implants.
-
Injectable Platelet-Rich Fibrin Added to MINST for Grade II Furcation Defects
Aiming to see if adding injectable platelet-rich fibrin to a minimally invasive non-surgical cleaning helps treat certain tooth defects better than MINST alone.
-
Injectable platelet-rich fibrin for faster orthodontic tooth movement
This study is testing if an injectable treatment made from platelets can help speed up tooth movement for people getting braces.
-
Digital planning for implants in the upper back jaw after a sinus lift
This project will test whether digital planning and the position of implants after a sinus lift affect bone levels, gum health, crown shape, and patient satisfaction in adults with implants in the upper back jaw.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.